AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29211279 — intervention group
Group type: COMPARATOR
Intervention: No rinse before dental scaling
Number of subjects: 54
Study 26630910 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity functional exercise program (intensive strengthening and balance exercises in small groups twice a week for 12 weeks)
Number of subjects: 170
Study 26630910 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity functional exercise program
Number of subjects: 170
Study 26630910 — intervention group
Group type: COMPARATOR
Intervention: Leisure activities (control group)
Number of subjects: 170
Study 24517948 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous-infusion elastomeric pump with local anesthetic (LA)
Number of subjects: 285
Study 24517948 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCA)
Number of subjects: 285
Study 20864217 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial trilayer gloves (group C)
Number of subjects: 0
Study 20864217 — intervention group
Group type: COMPARATOR
Intervention: Single-layer gloves (group A)
Number of subjects: 0
Study 20864217 — intervention group
Group type: COMPARATOR
Intervention: Double-layer gloves (group B)
Number of subjects: 0
Study 18443351 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 522
Study 18443351 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated serum TIMP-1
Number of subjects: 522
Study 16231250 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalbavancin (1000 mg IV on day 1 and 500 mg IV on day 8)
Number of subjects: 0
Study 16231250 — intervention group
Group type: COMPARATOR
Intervention: Linezolid (600 mg IV or orally every 12 hours for 14 days)
Number of subjects: 0
Study 16231250 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalbavancin
Number of subjects: 0
Study 16231250 — intervention group
Group type: COMPARATOR
Intervention: Linezolid
Number of subjects: 0
Study 16231250 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalbavancin and Linezolid
Number of subjects: 0
Study 12470424 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatic arterial infusion (HAI) of activated leukocytes after stimulation with GM-CSF
Number of subjects: 10
Study 12470424 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatic arterial infusion (HAI) of activated leukocytes after stimulation with IL-2
Number of subjects: 10
Study 12470424 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of HAI of melphalan (50 mg) and activated leukocytes
Number of subjects: 10
Study 12470424 — intervention group
Group type: COMPARATOR
Intervention: HAI of melphalan (50 mg) alone
Number of subjects: 10
Study 10517717 — intervention group
Group type: EXPERIMENTAL
Intervention: One-page, low-literacy educational handout encouraging patients to 'ask your doctor about the pneumonia shot'
Number of subjects: 433
Study 10517717 — intervention group
Group type: COMPARATOR
Intervention: One-page, low-literacy educational handout conveying information about nutrition (Control)
Number of subjects: 433
Study 7864411 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalaprilat (0.06 mg/kg)
Number of subjects: 14
Study 7864411 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (control group)
Number of subjects: 14
Study 1827641 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 lux white light for 40 minutes
Number of subjects: 10
Study 1827641 — intervention group
Group type: COMPARATOR
Intervention: 400 lux red light (placebo) for 40 minutes
Number of subjects: 10
Study 6952022 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised running (n = 48)
Number of subjects: 81
Study 6952022 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control (n = 33)
Number of subjects: 81
Study 31549286 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromonitorisation group (n=30)
Number of subjects: 61
Study 31549286 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=31)
Number of subjects: 61
Study 31088436 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Feedback (PF)
Number of subjects: 110
Study 31088436 — intervention group
Group type: COMPARATOR
Intervention: Negative Feedback (NF)
Number of subjects: 110
Study 28822046 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous abatacept (125 mg/week)
Number of subjects: 1456
Study 28822046 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous abatacept (10 mg/kg/month)
Number of subjects: 1456
Study 28822046 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous and Intravenous abatacept
Number of subjects: 1456
Study 26427563 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise arm (activity tracker, phone calls, tailored and non-tailored email content)
Number of subjects: 80
Study 26427563 — intervention group
Group type: COMPARATOR
Intervention: Control arm (emails on women's health topics)
Number of subjects: 80
Study 22510252 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS hydromorphone ER
Number of subjects: 112
Study 22510252 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone CR
Number of subjects: 112
Study 20947593 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.5 µg kg⁻¹ (R0.5 group, n=24)
Number of subjects: 48
Study 20947593 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 1 µg kg⁻¹ (R1.0 group, n=24)
Number of subjects: 48
Study 20947593 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of remifentanil
Number of subjects: 48
Study 19067065 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 2 microg/kg/min
Number of subjects: 32
Study 19067065 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion (Control)
Number of subjects: 32
Study 17636223 — intervention group
Group type: EXPERIMENTAL
Intervention: COMT Val158Met polymorphism
Number of subjects: 972
Study 15553818 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Salvia injection (CSI) plus conventional treatment of western medicine
Number of subjects: 64
Study 15553818 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 64
Study 16206673 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg/day)
Number of subjects: 52
Study 16206673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 9624237 — intervention group
Group type: EXPERIMENTAL
Intervention: CHART trial with dedicated local trials staff for administering quality of life questionnaires.
Number of subjects: 0
Study 9624237 — intervention group
Group type: COMPARATOR
Intervention: LU12 and LU13 trials without dedicated local trials staff.
Number of subjects: 0
Study 9624237 — intervention group
Group type: EXPERIMENTAL
Intervention: All trials (LU12, LU13, CHART) administering Rotterdam Symptom Checklist (RSCL) and Hospital Anxiety and Depression Scale (HADS).
Number of subjects: 0
Study 9624237 — intervention group
Group type: EXPERIMENTAL
Intervention: Measures implemented to improve compliance and standardisation.
Number of subjects: 0
Study 7659586 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite Rhythm file method for AF detection
Number of subjects: 20
Study 2544523 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict diastolic blood pressure (DBP) control (less than or equal to 80 mm Hg)
Number of subjects: 79
Study 2544523 — intervention group
Group type: COMPARATOR
Intervention: Conventional levels of diastolic blood pressure (90-95 mm Hg)
Number of subjects: 79
Study 4909450 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran 70
Number of subjects: 80
Study 4909450 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 80
Study 29546692 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplement of 4000 IU for 3 years
Number of subjects: 133
Study 29546692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 28894429 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (completed items on affective and cognitive attitudes)
Number of subjects: 349
Study 28894429 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (excluded affective attitudes)
Number of subjects: 349
Study 28894429 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (omitted negatively worded affective attitudes)
Number of subjects: 349
Study 25168752 — intervention group
Group type: EXPERIMENTAL
Intervention: RapidArc (RA)
Number of subjects: 157
Study 25168752 — intervention group
Group type: COMPARATOR
Intervention: Standard sliding window IMRT (swIMRT)
Number of subjects: 157
Study 24047668 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention program (including nutrition classes, group exercise, and enjoying meals with community members)
Number of subjects: 44
Study 24047668 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 21658262 — intervention group
Group type: EXPERIMENTAL
Intervention: Cameroon Mobile Phone SMS intervention
Number of subjects: 0
Study 19875974 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery followed by adjuvant treatment with tegafur-uracil (UFT)
Number of subjects: 1269
Study 19875974 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1269
Study 19875974 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT
Number of subjects: 1269
Study 16773286 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (prep group)
Number of subjects: 249
Study 16773286 — intervention group
Group type: COMPARATOR
Intervention: No mechanical bowel preparation (non-prep group)
Number of subjects: 249
Study 15296809 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary Modification (DM) component
Number of subjects: 161856
Study 15296809 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone-Replacement Therapy (HRT) component
Number of subjects: 161856
Study 15296809 — intervention group
Group type: EXPERIMENTAL
Intervention: African Americans in DM component
Number of subjects: 161856
Study 15296809 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanics in HRT component
Number of subjects: 161856
Study 15296809 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recruitment strategies
Number of subjects: 161856
Study 10936836 — intervention group
Group type: EXPERIMENTAL
Intervention: Infiltration anesthesia with 3.6 mL of lidocaine with 1:80,000 epinephrine (L-E)
Number of subjects: 21
Study 10936836 — intervention group
Group type: COMPARATOR
Intervention: Ergometer-stress testing at 25 watts (W) for young subjects and at 15 W for older subjects
Number of subjects: 21
Study 9555218 — intervention group
Group type: EXPERIMENTAL
Intervention: Helioseal F
Number of subjects: 62
Study 9555218 — intervention group
Group type: COMPARATOR
Intervention: Delton opaque (unfilled control)
Number of subjects: 62
Study 8335655 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 25
Study 8335655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 2906476 — intervention group
Group type: EXPERIMENTAL
Intervention: olsalazine, 3 g/day
Number of subjects: 56
Study 2906476 — intervention group
Group type: COMPARATOR
Intervention: sulphasalazine, 3 g/day
Number of subjects: 56
Study 2906476 — intervention group
Group type: EXPERIMENTAL
Intervention: olsalazine
Number of subjects: 56
Study 2906476 — intervention group
Group type: COMPARATOR
Intervention: sulphasalazine
Number of subjects: 56
Study 31191101 — intervention group
Group type: EXPERIMENTAL
Intervention: 4x5 repetition maximum band-resisted squat jumps
Number of subjects: 12
Study 31191101 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 12
Study 28740945 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration Exercises once per week (WBVE1)
Number of subjects: 0
Study 28740945 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration Exercises twice per week (WBVE2)
Number of subjects: 0
Study 28740945 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study 26836268 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil supplementation for 8 weeks
Number of subjects: 0
Study 26836268 — intervention group
Group type: COMPARATOR
Intervention: Placebo intake for 8 weeks
Number of subjects: 0
Study 23397984 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief educational program (six-sessions) for parents
Number of subjects: 103
Study 23397984 — intervention group
Group type: COMPARATOR
Intervention: Control group (parents not given the intervention)
Number of subjects: 103
Study 21942748 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercise (simplified Buteyko technique) with easy task instructions
Number of subjects: 57
Study 21942748 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercise (simplified Buteyko technique) with difficult task instructions
Number of subjects: 57
Study 21942748 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 57
Study 18696039 — intervention group
Group type: COMPARATOR
Intervention: Standard lymphadenectomy (obturator and external nodes)
Number of subjects: 19
Study 18696039 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy (complete pelvic nodes up to the inferior mesenteric artery)
Number of subjects: 19
Study 18696039 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of occult disseminated tumor cells using RT-PCR
Number of subjects: 19
Study 20090483 — intervention group
Group type: EXPERIMENTAL
Intervention: Tono-Pen XL
Number of subjects: 52
Study 20090483 — intervention group
Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometer (GAT)
Number of subjects: 52
Study 20090483 — intervention group
Group type: COMPARATOR
Intervention: Tono-Pen XL and GAT
Number of subjects: 52
Study 15620953 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathoracoscopic ultrasound (group A)
Number of subjects: 50
Study 15620953 — intervention group
Group type: COMPARATOR
Intervention: Finger palpation (group A)
Number of subjects: 50
Study 15620953 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio-guided technique (group B)
Number of subjects: 50
Study 15620953 — intervention group
Group type: COMPARATOR
Intervention: Finger palpation (group B)
Number of subjects: 50
Study 15620953 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound technique
Number of subjects: 50
Study 15620953 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio-guided technique
Number of subjects: 50
Study 12372097 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloesin treatment (administered four times a day for 15 days)
Number of subjects: 15
Study 12372097 — intervention group
Group type: EXPERIMENTAL
Intervention: Arbutin treatment (administered four times a day for 15 days)
Number of subjects: 15
Study 12372097 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloesin and arbutin cotreatment (administered four times a day for 15 days)
Number of subjects: 15
Study 12372097 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloesin treatment (dose-dependent)
Number of subjects: 15
Study 12372097 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 15
Study 9532967 — intervention group
Group type: EXPERIMENTAL
Intervention: Random interval repetition task
Number of subjects: 0
Study 9532967 — intervention group
Group type: COMPARATOR
Intervention: Single-task random-interval repetition performance
Number of subjects: 0
Study 8023079 — intervention group
Group type: EXPERIMENTAL
Intervention: Group gymnastics for neck pain (45 min once a week for 10 weeks)
Number of subjects: 44
Study 8023079 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 44
Study 2470000 — intervention group
Group type: EXPERIMENTAL
Intervention: COP-BLAM (5 courses)
Number of subjects: 349
Study 2470000 — intervention group
Group type: EXPERIMENTAL
Intervention: IMVP-16 (2 courses)
Number of subjects: 349
Study 2470000 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment strategy
Number of subjects: 349
Study 2470000 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose reductions and interval prolongations
Number of subjects: 349
Study 2470000 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapses
Number of subjects: 349
Study 1096275 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenazone 600 mg
Number of subjects: 20
Study 1096275 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 4 g daily
Number of subjects: 20
Study 31076856 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation (folic acid 400 µg and vitamin B12 500 µg)
Number of subjects: 2919
Study 31076856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2919
Study 31076856 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational data
Number of subjects: 2919
Study 30173939 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi with music
Number of subjects: 112
Study 30173939 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112
Study 29980493 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg)
Number of subjects: 30
Study 29980493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 27828579 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-motor physiotherapy intervention (4 months, single weekly visit)
Number of subjects: 15
Study 27828579 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 15
Study 25104582 — intervention group
Group type: EXPERIMENTAL
Intervention: 3g of sea buckthorn (SB) oil daily
Number of subjects: 116
Study 25104582 — intervention group
Group type: COMPARATOR
Intervention: Placebo oil
Number of subjects: 116
Study 23082956 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate sodium intake (180 mmol/day)
Number of subjects: 0
Study 23082956 — intervention group
Group type: COMPARATOR
Intervention: Low sodium intake (60 mmol/day)
Number of subjects: 0
Study 23082956 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 0
Study 19681738 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise for 30 minutes, five days per week, for eight weeks.
Number of subjects: 44
Study 19681738 — intervention group
Group type: COMPARATOR
Intervention: Usual activities with no specific exercise (Control group).
Number of subjects: 44
Study 17963431 — intervention group
Group type: EXPERIMENTAL
Intervention: MN 001 (750 mg twice daily)
Number of subjects: 705
Study 17963431 — intervention group
Group type: EXPERIMENTAL
Intervention: MN 001 (500 mg three times daily)
Number of subjects: 705
Study 17963431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 705
Study 15114532 — intervention group
Group type: EXPERIMENTAL
Intervention: HbE variant
Number of subjects: 0
Study 11449671 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of argatroban (10 mg/day, three times a week)
Number of subjects: 55
Study 9482129 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil SR 240 mg (V)
Number of subjects: 26
Study 9482129 — intervention group
Group type: COMPARATOR
Intervention: amiloride 5 mg + hydrochlorothiazide 50 mg (AH)
Number of subjects: 26
Study 8304488 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II infusion to maintain plasma ANG II levels at around basal values (6.6 ± 1.6 pmol/l)
Number of subjects: 8
Study 8304488 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control day)
Number of subjects: 8
Study 8304488 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of aldosterone (previous study)
Number of subjects: 8
Study 2541981 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglycolic acid (PGA)
Number of subjects: 300
Study 2541981 — intervention group
Group type: COMPARATOR
Intervention: Polyester
Number of subjects: 300
Study 2541981 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglycolic acid (PGA) in men
Number of subjects: 300
Study 2541981 — intervention group
Group type: COMPARATOR
Intervention: Polyester in men
Number of subjects: 300
Study 2541981 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglycolic acid (PGA) with risk factors (obesity, bronchitis, recurrent hernia, size of hernial sac > 8 cm)
Number of subjects: 300
Study 2541981 — intervention group
Group type: COMPARATOR
Intervention: Polyester with risk factors (obesity, bronchitis, recurrent hernia, size of hernial sac > 8 cm)
Number of subjects: 300
Study 29973241 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for traditional midwives including a small stipend, a scholarship to train one apprentice, and support from an intercultural broker; workshops for health staff in intervention municipalities.
Number of subjects: 8000
Study 29973241 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for traditional midwives
Number of subjects: 8000
Study 29973241 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 8000
Study 27098638 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 48
Study 27098638 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase
Number of subjects: 48
Study 27098638 — intervention group
Group type: COMPARATOR
Intervention: Both phases
Number of subjects: 48
Study 25677736 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive Therapy (MCT)
Number of subjects: 48
Study 25677736 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 48
Study 25104262 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated counselling
Number of subjects: 3415
Study 25104262 — intervention group
Group type: COMPARATOR
Intervention: Traditional counselling
Number of subjects: 3415
Study 25104262 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced linkage to care
Number of subjects: 3415
Study 25104262 — intervention group
Group type: COMPARATOR
Intervention: Standard linkage to care
Number of subjects: 3415
Study 20507844 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosdex online decision aid
Number of subjects: 82
Study 18237592 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 40 mg
Number of subjects: 271
Study 18237592 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 80 mg
Number of subjects: 271
Study 16617228 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular walking
Number of subjects: 123
Study 16617228 — intervention group
Group type: COMPARATOR
Intervention: Standard care (irregular walkers)
Number of subjects: 123
Study 12356658 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 131